Patents by Inventor Nathan N. Bass

Nathan N. Bass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of skin conditions with FXR activators
    Patent number: 6187814
    Abstract: Disorders of the skin and mucous membranes that have a disrupted or dysfunctional epidermal barrier are treated or prevented by topical application of compounds that are either activators of the farnesoid X receptor, activators of the peroxisome proliferator-activated receptor &agr;, and oxysterol activators of the LXR&agr; receptor. The same compounds are also effective in treating disorders of epidermal differentiation and proliferation.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: February 13, 2001
    Assignee: The Regents of the University of California
    Inventors: Peter M. Elias, Nathan N. Bass, Karen Hanley, Kenneth R. Feingold
  • Treatment of skin conditions with oxysterol activators of LXR&agr;
    Patent number: 6184215
    Abstract: Disorders of the skin and mucous membranes that have a disrupted or dysfunctional epidermal barrier are treated or prevented by topical application of compounds that are either activators of the farnesoid X receptor, activators of the peroxisome proliferator-activated receptor &agr;, and oxysterol activators of the LXR&agr; receptor. The same compounds are also effective in treating disorders of epidermal differentiation and proliferation.
    Type: Grant
    Filed: August 24, 1999
    Date of Patent: February 6, 2001
    Assignee: The Regents of the University of California
    Inventors: Peter M. Elias, Nathan N. Bass, Karen Hanley, Kenneth R. Feingold
  • Treatment of skin conditions by use of PPAR.alpha. activators
    Patent number: 6060515
    Abstract: Disorders of the skin and mucous membrane that have a disrupted or dysfunctional epidermal barrier are treated or prevented by topical application of compounds that are either activators of the farnesoid X receptor, activators of the peroxisome proliferator-activated receptor .alpha., and oxysterol activators of the LXR.alpha. receptor. The same compounds are also effective in treating disorders of epidermal differentiation and proliferation.
    Type: Grant
    Filed: June 16, 1999
    Date of Patent: May 9, 2000
    Assignee: The Regents of the University of California
    Inventors: Peter M. Elias, Nathan N. Bass, Karen Hanley, Kenneth R. Feingold
  • Treatment of skin conditions by use of PPAR&agr; activators
    Patent number: RE37770
    Abstract: Disorders of the skin and mucous membrane that have a disrupted or dysfunctional epidermal barrier are treated or prevented by topical application of compounds that are either activators of the farnesoid X receptor, activators of the peroxisome proliferator-activated receptor &agr;, and oxysterol activators of the LXR&agr; receptor. The same compounds are also effective in treating disorders of epidermal differentiation and proliferation.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: June 25, 2002
    Assignee: The Regents of the University of California
    Inventors: Peter M. Elias, Nathan N. Bass, Karen Hanley, Kenneth R. Feingold